🇺🇸 FDA
Patent

US 12329816

Immunotherapy with metabolic enzyme expression

granted A61KA61K38/50A61K40/11

Quick answer

US patent 12329816 (Immunotherapy with metabolic enzyme expression) held by THE TRUSTEES OF PRINCETON UNIVERSITY expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE TRUSTEES OF PRINCETON UNIVERSITY
Grant date
Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/50, A61K40/11, A61K40/31, A61K40/4255